Actively Recruiting
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
Led by Qilu Hospital of Shandong University · Updated on 2023-11-18
200
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic lupus erythematosus (SLE) is a kind of systemic autoimmune disease which can cause multiple organs and system damage, which often occurs in women of childbearing age. Compared with healthy pregnant women, SLE patients have higher incidence of premature delivery, preeclampsia and fetal loss during pregnancy. Since SLE patients usually have disease activity during pregnancy and postpartum, and a variety of maternal and fetal diseases are closely related to SLE, it is very important to monitor the disease activity and drug treatment of SLE patients during pregnancy.
CONDITIONS
Official Title
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with systemic lupus erythematosus (SLE) according to ACR criteria (1997)
- Pregnant women aged 20 to 45 years
- Willing to participate, follow the treatment plan, and sign informed consent
You will not qualify if you...
- Known cause of previous abortion including chromosomal abnormalities or endocrine dysfunction
- Abnormal anatomy of the uterus or serious infections like hepatitis B or C, HIV, syphilis, or tuberculosis
- Allergic to prednisone, hydroxychloroquine, low molecular weight heparin, or aspirin
- History of peptic ulcer, upper gastrointestinal bleeding, malignant tumor, epilepsy, or psychosis
- Unable or unwilling to complete follow-up during pregnancy and after delivery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qilu Hospital
Jinan, Shandong, China, 250012
Actively Recruiting
Research Team
Q
Qiang Shu, Dr.
CONTACT
Y
Yunfei Guo, Bachelor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here